ALLERGEN-MEDIATED ASTHMA: A MEDICAID PERSPECTIVE ON THE ROLE OF IgE-Blocker Therapy
View this CME event Now.
This is the second in a series of high-level webcasts featuring nationally recognized experts in the fields of Allergy, Pulmonology and state Medicaid Programs. Directed at Medicaid medical
directors, providers and policy makers, this CME
accredited webcast highlights the public health issues surrounding
allergen-mediated asthma and includes candid discussions about the potential
role of IgE-Blocker therapy in managing patients and populations with moderate-
to severe-persistent, allergy-based, asthma.
Moderated by David B. Nash, MD, MBA, Chairman, Department of Health Policy at Jefferson Medical College, the expert panel includes:
William Calhoun, MD - Director of Asthma, Allergy
and Airway Center, University of Pittsburgh, PA (Pulmonology)
Theodore Christopher, MD - Thomas Jefferson University,
PA (Emergency Medicine)
Allan T. Luskin, MD - Director of Center for
Respiratory Health, University of Wisconsin, WI (Allergy)
Craig A. Jones, MD - University of Southern California,
CA (Breath Mobile Asthma Clinic Program with LA County Dept. of
Public Health)
John Searcy, MD - Alabama Medicaid Agency
Program Goals:
To raise the general awareness of new and emerging therapies for the treatment
of allergic asthma, specifically IgE blockers;
To educate individual Medicaid directors, providers, and purchasers as
well as the health care system as a whole by providing important information
on the role of IgE blockers as part of asthma treatment to help improve health
care quality;
To support the use of IgE blockers through evidence-based medicine; and
To discuss the role of biologics in a Medicaid plans in terms of fulfilling
an unmet medical need.
Leaning Objectives:
Discuss new and emerging therapies for the treatment of allergic asthma,
specifically IgE blockers;
Assess the role of IgE blockers as part of asthma treatment to help improve
health care quality from a Medicaid perspective;
Understand the use of IgE blockers through evidence-based medicine; and
Determine the role of biologics in Medicaid plans in terms of fulfilling
an unmet medical need.
It is not necessary to purchase any of Real's premium players or subscription
plans. The free basic player is all that is required to view the surgery.
Supported by an unrestricted educational grant from Genentech.
Jefferson Medical College of Thomas Jefferson University,
as a member of the Consortium for Academic Continuing Medical
Education, is accredited by the ACCME to provide continuing
medical education for physicians.
This activity has been planned and implemented in accordance
with the Essential Areas and Policies of the Accreditation
Council for Continuing Medical Education (ACCME). Jefferson
Medical College designates this educational activity for a
maximum of 1 Category 1 credits towards the AMA Physician's
Recognition Award. Each physician should claim only those credits
that he/she actually spent in the educational activity.
The Department of Health Policy, Jefferson
Medical College , is accredited by the Accreditation Council
on Pharmacy Education (ACPE) as a provider of continuing
pharmaceutical education and complies with the Quality Criteria
for continuing pharmaceutical education programming. This
program (079-999-04-032-H01) is acceptable for 1 hours of
continuing pharmacy education credit (0.1 CEUs) in states
that recognize ACPE-accredited providers. Statements of Credit
indicating hours/CEUs will be mailed within 6-8 weeks to
participants who complete this activity and submit required
participant information, including evaluation and mailing
address.
First Webcast in Series on Allergic Asthma
